These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 17989316)

  • 21. Interleukin-6 biology is coordinated by membrane-bound and soluble receptors: role in inflammation and cancer.
    Rose-John S; Scheller J; Elson G; Jones SA
    J Leukoc Biol; 2006 Aug; 80(2):227-36. PubMed ID: 16707558
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IL-6 regulates neutrophil trafficking during acute inflammation via STAT3.
    Fielding CA; McLoughlin RM; McLeod L; Colmont CS; Najdovska M; Grail D; Ernst M; Jones SA; Topley N; Jenkins BJ
    J Immunol; 2008 Aug; 181(3):2189-95. PubMed ID: 18641358
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Minimal role for STAT1 in interleukin-6 signaling and actions in the murine brain.
    Sanz E; Hofer MJ; Unzeta M; Campbell IL
    Glia; 2008 Jan; 56(2):190-9. PubMed ID: 18023015
    [TBL] [Abstract][Full Text] [Related]  

  • 24. IL6 Receptor Blockade Enhances Chemotherapy Efficacy in Pancreatic Ductal Adenocarcinoma.
    Long KB; Tooker G; Tooker E; Luque SL; Lee JW; Pan X; Beatty GL
    Mol Cancer Ther; 2017 Sep; 16(9):1898-1908. PubMed ID: 28611107
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of Polymorphisms of IL-6 Pathway Genes (IL6, IL6R and IL6ST) with COVID-19 Severity in an Amazonian Population.
    Rodrigues FBB; da Silva R; Santos EFD; de Brito MTFM; da Silva ALS; de Meira Leite M; Póvoa da Costa F; de Nazaré do Socorro de Almeida Viana M; de Sarges KML; Cantanhede MHD; Veríssimo AOL; Carvalho MDS; Henriques DF; Silva CPD; Costa IB; Nunes JAL; Costa IB; Viana GMR; Queiroz MAF; Lima SS; Lopes JDC; Torres MKDS; Vallinoto IMVC; Bichara CDA; Vallinoto ACR; Santos EJMD
    Viruses; 2023 May; 15(5):. PubMed ID: 37243282
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interleukin-6 and its receptors: a highly regulated and dynamic system.
    Wolf J; Rose-John S; Garbers C
    Cytokine; 2014 Nov; 70(1):11-20. PubMed ID: 24986424
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Therapeutic Interleukin-6 Trans-signaling Inhibition by Olamkicept (sgp130Fc) in Patients With Active Inflammatory Bowel Disease.
    Schreiber S; Aden K; Bernardes JP; Conrad C; Tran F; Höper H; Volk V; Mishra N; Blase JI; Nikolaus S; Bethge J; Kühbacher T; Röcken C; Chen M; Cottingham I; Petri N; Rasmussen BB; Lokau J; Lenk L; Garbers C; Feuerhake F; Rose-John S; Waetzig GH; Rosenstiel P
    Gastroenterology; 2021 Jun; 160(7):2354-2366.e11. PubMed ID: 33667488
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Functional expression of a biologically active fragment of soluble gp130 as an ELP-fusion protein in transgenic plants: purification via inverse transition cycling.
    Lin M; Rose-John S; Grötzinger J; Conrad U; Scheller J
    Biochem J; 2006 Sep; 398(3):577-83. PubMed ID: 16716147
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Therapeutic targeting of IL-6 trans-signaling.
    Rose-John S
    Cytokine; 2021 Aug; 144():155577. PubMed ID: 34022535
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Soluble gp130 prevents interleukin-6 and interleukin-11 cluster signaling but not intracellular autocrine responses.
    Lamertz L; Rummel F; Polz R; Baran P; Hansen S; Waetzig GH; Moll JM; Floss DM; Scheller J
    Sci Signal; 2018 Oct; 11(550):. PubMed ID: 30279168
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A study of genes encoding cytokines (IL6, IL10, TNF), cytokine receptors (IL6R, IL6ST), and glucocorticoid receptor (NR3C1) and susceptibility to bronchopulmonary dysplasia.
    Huusko JM; Karjalainen MK; Mahlman M; Haataja R; Kari MA; Andersson S; Toldi G; Tammela O; Rämet M; Lavoie PM; Hallman M;
    BMC Med Genet; 2014 Nov; 15():120. PubMed ID: 25409741
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The varying faces of IL-6: From cardiac protection to cardiac failure.
    Fontes JA; Rose NR; Čiháková D
    Cytokine; 2015 Jul; 74(1):62-8. PubMed ID: 25649043
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuroprotective effect of interleukin-6 and IL6/IL6R chimera in the quinolinic acid rat model of Huntington's syndrome.
    Bensadoun JC; de Almeida LP; Dréano M; Aebischer P; Déglon N
    Eur J Neurosci; 2001 Dec; 14(11):1753-61. PubMed ID: 11860469
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structure-guided optimization of the interleukin-6 trans-signaling antagonist sgp130.
    Tenhumberg S; Waetzig GH; Chalaris A; Rabe B; Seegert D; Scheller J; Rose-John S; Grötzinger J
    J Biol Chem; 2008 Oct; 283(40):27200-7. PubMed ID: 18650419
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Soluble gp130 is the natural inhibitor of soluble interleukin-6 receptor transsignaling responses.
    Jostock T; Müllberg J; Ozbek S; Atreya R; Blinn G; Voltz N; Fischer M; Neurath MF; Rose-John S
    Eur J Biochem; 2001 Jan; 268(1):160-7. PubMed ID: 11121117
    [TBL] [Abstract][Full Text] [Related]  

  • 36. NFAT1-regulated IL6 signalling contributes to aggressive phenotypes of glioma.
    Jiang Y; Han S; Cheng W; Wang Z; Wu A
    Cell Commun Signal; 2017 Dec; 15(1):54. PubMed ID: 29258522
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The balance of interleukin (IL)-6, IL-6·soluble IL-6 receptor (sIL-6R), and IL-6·sIL-6R·sgp130 complexes allows simultaneous classic and trans-signaling.
    Baran P; Hansen S; Waetzig GH; Akbarzadeh M; Lamertz L; Huber HJ; Ahmadian MR; Moll JM; Scheller J
    J Biol Chem; 2018 May; 293(18):6762-6775. PubMed ID: 29559558
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The pro- and anti-inflammatory properties of the cytokine interleukin-6.
    Scheller J; Chalaris A; Schmidt-Arras D; Rose-John S
    Biochim Biophys Acta; 2011 May; 1813(5):878-88. PubMed ID: 21296109
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Response to IL-6 trans- and IL-6 classic signalling is determined by the ratio of the IL-6 receptor α to gp130 expression: fusing experimental insights and dynamic modelling.
    Reeh H; Rudolph N; Billing U; Christen H; Streif S; Bullinger E; Schliemann-Bullinger M; Findeisen R; Schaper F; Huber HJ; Dittrich A
    Cell Commun Signal; 2019 May; 17(1):46. PubMed ID: 31101051
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chikusetsusaponin IVa Butyl Ester (CS-IVa-Be), a Novel IL6R Antagonist, Inhibits IL6/STAT3 Signaling Pathway and Induces Cancer Cell Apoptosis.
    Yang J; Qian S; Cai X; Lu W; Hu C; Sun X; Yang Y; Yu Q; Gao SP; Cao P
    Mol Cancer Ther; 2016 Jun; 15(6):1190-200. PubMed ID: 26929249
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.